Condition: Normal Weight · Overweight and Obesity · Insulin Sensitivity · Sponsor: University Hospital Tuebingen
The overarching goal of the current study is to investigate the effect of GLP-1 on brain insulin responsiveness in a randomized, single-blinded, within subject cross-over study design. To this end, investigators will compare the effect of the administration of semaglutide versus placebo, followed by an fMRI with administration of intranasal insulin or placebo.
This description comes directly from the study's public registry record.
Stephanie Kullmann, PhD · 0049707129 · stephanie.kullmann@med.uni-tuebingen.de
Always discuss trial participation with your own doctor first.
| University Clinic Tubingen, Department of Internal Medicine IV | Tübingen, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06487832